Pages

Monday, December 2, 2013

IMPORTANT! FDA Draft Guidance Interim Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act

No comments:

Post a Comment